Network models in drug discovery and regenerative medicine.
暂无分享,去创建一个
[1] Julio Caballero,et al. 2D Autocorrelation modeling of the negative inotropic activity of calcium entry blockers using Bayesian-regularized genetic neural networks. , 2006, Bioorganic & medicinal chemistry.
[2] David A Winkler,et al. Application of neural networks to large dataset QSAR, virtual screening, and library design. , 2002, Methods in molecular biology.
[3] D. Knight,et al. A new approach to the rationale discovery of polymeric biomaterials. , 2007, Biomaterials.
[4] Henry Yang,et al. Mechanisms controlling embryonic stem cell self-renewal and differentiation. , 2006, Critical reviews in eukaryotic gene expression.
[5] D. Knight,et al. Prediction of Fibrinogen Adsorption for Biodegradable Polymers: Integration of Molecular Dynamics and Surrogate Modeling. , 2007, Polymer.
[6] David A Winkler,et al. Neural networks as robust tools in drug lead discovery and development , 2004, Molecular biotechnology.
[7] Daniel A. Lidar,et al. Is the Geometry of Nature Fractal? , 1998, Science.
[8] S. Huang,et al. Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation. , 2001, Pharmacogenomics.
[9] Wei Sun,et al. Application of Bayesian Regularized BP Neural Network Model for Trend Analysis, Acidity and Chemical Composition of Precipitation in North Carolina , 2006 .
[10] D Sardari,et al. Applications of artificial neural network in AIDS research and therapy. , 2002, Current pharmaceutical design.
[11] R. Rojas,et al. Glass transition temperature prediction of polymers through the mass-per-flexible-bond principle. , 2007, Polymer.
[12] Johann Gasteiger,et al. Neural networks and genetic algorithms in drug design , 2001 .
[13] Igor V. Tetko,et al. Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..
[14] Jure Zupan,et al. Neural networks in chemistry , 1993 .
[15] István A. Kovács,et al. How to design multi-target drugs , 2007, Expert opinion on drug discovery.
[16] Julio Caballero,et al. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives. , 2007, Bioorganic & medicinal chemistry.
[17] William J. Welsh,et al. Using Surrogate Modeling in the Prediction of Fibrinogen Adsorption onto Polymer Surfaces , 2004, J. Chem. Inf. Model..
[18] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[19] Mário A. T. Figueiredo. Adaptive Sparseness for Supervised Learning , 2003, IEEE Trans. Pattern Anal. Mach. Intell..
[20] Julio Caballero,et al. Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and Bayesian-regularized neural networks , 2006, Journal of molecular modeling.
[21] Mark E. J. Newman,et al. The Structure and Function of Complex Networks , 2003, SIAM Rev..
[22] J. Doyle,et al. Reverse Engineering of Biological Complexity , 2002, Science.
[23] Ting Chen,et al. Ensemble Feature Selection: Consistent Descriptor Subsets for Multiple QSAR Models , 2007, J. Chem. Inf. Model..
[24] Luke E. K. Achenie,et al. A network model for gene regulation , 2007, Comput. Chem. Eng..
[25] R. Sharma,et al. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis. , 2005, Stem cells and development.
[26] Robin Lovell-Badge,et al. The future for stem cell research , 2001, Nature.
[27] Ş. Niculescu. Artificial neural networks and genetic algorithms in QSAR , 2003 .
[28] Aris Floratos,et al. QSAR in grossly underdetermined systems : Opportunities and issues Regression , 2001 .
[29] W. Tong,et al. Quantitative structure‐activity relationship methods: Perspectives on drug discovery and toxicology , 2003, Environmental toxicology and chemistry.
[30] Gisbert Schneider,et al. Neural networks are useful tools for drug design , 2000, Neural Networks.
[31] Leilei Pan,et al. Intelligent Computation of Moisture Content in Shrinkable Biomaterials , 2007 .
[32] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[33] P. Robson,et al. Transcriptional Regulation of Nanog by OCT4 and SOX2* , 2005, Journal of Biological Chemistry.
[34] H Ichikawa,et al. Neural networks applied to pharmaceutical problems. I. Method and application to decision making. , 1989, Chemical & pharmaceutical bulletin.
[35] G. Church,et al. Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae , 2001, Nature Genetics.
[36] N. Goldenfeld,et al. Coarse-graining of cellular automata, emergence, and the predictability of complex systems. , 2005, Physical review. E, Statistical, nonlinear, and soft matter physics.
[37] A. Barabasi,et al. Human disease classification in the postgenomic era: A complex systems approach to human pathobiology , 2007, Molecular systems biology.
[38] Jens Sadowski,et al. The Use of Self-organizing Neural Networks in Drug Design , 2002 .
[39] J. Gasteiger,et al. Neural networks as data mining tools in drug design , 2003 .
[40] D. Manallack,et al. Neural networks in drug discovery: Have they lived up to their promise? , 1999 .
[41] Stuart A. Kauffman,et al. The ensemble approach to understand genetic regulatory networks , 2004 .
[42] Julio Caballero,et al. Modeling of acetylcholinesterase inhibition by tacrine analogues using Bayesian-regularized Genetic Neural Networks and ensemble averaging , 2006, Journal of enzyme inhibition and medicinal chemistry.
[43] Bruno Bienfait. Applications of High-Resolution Self-Organizing Maps to Retrosynthetic and QSAR Analysis , 1994, J. Chem. Inf. Comput. Sci..
[44] David A. Winkler,et al. Neural networks in ADME and toxicity prediction , 2004 .
[45] R. Ozawa,et al. A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] R. García-Domenech,et al. Some new trends in chemical graph theory. , 2008, Chemical reviews.
[47] E. Rothenberg,et al. Transcriptional regulation of lymphocyte lineage commitment , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[48] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[49] David W. Opitz,et al. Use of Statistical and Neural Net Approaches in Predicting Toxicity of Chemicals , 2000, J. Chem. Inf. Comput. Sci..
[50] Walter Cedeño,et al. On the Use of Neural Network Ensembles in QSAR and QSPR , 2002, J. Chem. Inf. Comput. Sci..
[51] J. Doyle,et al. Bow Ties, Metabolism and Disease , 2022 .
[52] Russell Greiner,et al. Learning Bayesian Belief Network Classifiers: Algorithms and System , 2001, Canadian Conference on AI.
[53] R. Cramer,et al. Recent advances in comparative molecular field analysis (CoMFA). , 1989, Progress in clinical and biological research.
[54] Doyle Knight,et al. QSAR Models for the Analysis of Bioresponse Data from Combinatorial Libraries of Biomaterials , 2005 .
[55] Maykel Pérez González,et al. Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches. , 2006, Bioorganic & medicinal chemistry.
[56] Janet Wiles,et al. A Gene Network Model for Developing Cell Lineages , 2005, Artificial Life.
[57] F. Burden,et al. A quantitative structure--activity relationships model for the acute toxicity of substituted benzenes to Tetrahymena pyriformis using Bayesian-regularized neural networks. , 2000, Chemical research in toxicology.
[58] Julio Caballero,et al. QSAR models for predicting the activity of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists derived from erythromycin A using quantum chemical properties , 2007, Journal of molecular modeling.
[59] Guangjin Pan,et al. Nanog and transcriptional networks in embryonic stem cell pluripotency , 2007, Cell Research.
[60] H. Kitano. A robustness-based approach to systems-oriented drug design , 2007, Nature Reviews Drug Discovery.
[61] Ajay. A unified framework for using neural networks to build QSARs. , 1993, Journal of medicinal chemistry.
[62] E. Kawasaki,et al. Comparisons between transcriptional regulation and RNA expression in human embryonic stem cell lines. , 2006, Stem cells and development.
[63] D. Fell,et al. The small world inside large metabolic networks , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[64] H. Herrmann,et al. Self-organized criticality on small world networks , 2001, cond-mat/0110239.
[65] Bernhard O Palsson,et al. The global transcriptional regulatory network for metabolism in Escherichia coli exhibits few dominant functional states. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[66] D. Knight,et al. Predicting fibrinogen adsorption to polymeric surfaces in silico: a combined method approach , 2005 .
[67] Eric Mjolsness,et al. Connectivity in the Yeast Cell Cycle Transcription Network: Inferences from Neural Networks , 2006, PLoS Comput. Biol..
[68] A. Hopkins. Network pharmacology , 2007, Nature Biotechnology.
[69] S. Pal,et al. Bioinformatics in neurocomputing framework , 2005 .
[70] John Finnigan. The science of complex systems , 2005 .
[71] D Husmeier,et al. Reverse engineering of genetic networks with Bayesian networks. , 2003, Biochemical Society transactions.
[72] John P. Overington,et al. Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.
[73] A. Barabasi,et al. A Protein–Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration , 2006, Cell.
[74] Dirk Husmeier,et al. Sensitivity and specificity of inferring genetic regulatory interactions from microarray experiments with dynamic Bayesian networks , 2003, Bioinform..
[75] J. Topliss,et al. Chance correlations in structure-activity studies using multiple regression analysis , 1972 .
[76] Jiang Zhu,et al. Molecular pathways regulating the self-renewal of hematopoietic stem cells. , 2004, Experimental hematology.
[77] Pedro Larrañaga,et al. A review of feature selection techniques in bioinformatics , 2007, Bioinform..
[78] David J. Livingstone,et al. The Use of Artificial Neural Networks in QSAR , 1992 .
[79] M. Tyers,et al. From large networks to small molecules. , 2004, Current opinion in chemical biology.
[80] Dave Winkler. The broader applications of neural and genetic modelling methods. , 2001, Drug discovery today.
[81] Ying Liu,et al. A Comparative Study on Feature Selection Methods for Drug Discovery , 2004, J. Chem. Inf. Model..
[82] Johann Gasteiger,et al. Self-organizing maps for identification of new inhibitors of P-glycoprotein. , 2007, Journal of medicinal chemistry.
[83] Magdalena Zernicka-Goetz,et al. Cleavage pattern and emerging asymmetry of the mouse embryo , 2005, Nature Reviews Molecular Cell Biology.
[84] Riccardo Leonardi,et al. Caco-2 cell permeability modelling: a neural network coupled genetic algorithm approach , 2007, J. Comput. Aided Mol. Des..
[85] M G Ford,et al. Selecting compounds for focused screening using linear discriminant analysis and artificial neural networks. , 2004, Journal of molecular graphics & modelling.
[86] B. Gardiner,et al. Transcriptional analysis of early lineage commitment in human embryonic stem cells , 2007, BMC Developmental Biology.
[87] Masanori Arita,et al. Scale-freeness and biological networks. , 2005, Journal of biochemistry.
[88] Min Xu,et al. Application of Bayesian regularized BP neural network model for analysis of aquatic ecological data-a case study of chlorophyll-a prediction in Nanzui water area of Dongting Lake. , 2005, Journal of environmental sciences.
[89] Ziding Zhang,et al. Similarity networks of protein binding sites , 2005, Proteins.
[90] F. Burden,et al. New QSAR Methods Applied to Structure—Activity Mapping and Combinatorial Chemistry. , 1999 .
[91] Frank R. Burden,et al. Predictive Human Intestinal Absorption QSAR Models Using Bayesian Regularized Neural Networks , 2005 .
[92] S. Orkin,et al. Chipping away at the Embryonic Stem Cell Network , 2005, Cell.
[93] Daniel C. Weaver. Applying data mining techniques to library design, lead generation and lead optimization. , 2004, Current opinion in chemical biology.
[94] Tomoo Aoyama,et al. Obtaining the correlation indices between drug activity and structural parameters using a neural network , 1991 .
[95] F. Burden,et al. Robust QSAR models using Bayesian regularized neural networks. , 1999, Journal of medicinal chemistry.
[96] J Gasteiger,et al. Checking the projection display of multivariate data with colored graphs. , 1997, Journal of molecular graphics & modelling.
[97] Michal Linial,et al. Using Bayesian Networks to Analyze Expression Data , 2000, J. Comput. Biol..
[98] Jiang Zhu,et al. Hematopoietic cytokines, transcription factors and lineage commitment , 2002, Oncogene.
[99] M. Xiong,et al. Identification of genetic networks. , 2004, Genetics.
[100] J. Rich,et al. Malignant glioma drug discovery – targeting protein kinases , 2007, Expert opinion on drug discovery.
[101] S. Strogatz. Exploring complex networks , 2001, Nature.
[102] David A Winkler,et al. Modelling blood-brain barrier partitioning using Bayesian neural nets. , 2004, Journal of molecular graphics & modelling.
[103] Igor V. Tetko,et al. Data modelling with neural networks: Advantages and limitations , 1997, J. Comput. Aided Mol. Des..
[104] E. Stüssi,et al. Prediction of elasticity constants in small biomaterial samples such as bone. A comparison between classical optimization techniques and identification with artificial neural networks , 2004, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.
[105] Massimo Marchiori,et al. Error and attacktolerance of complex network s , 2004 .
[106] Xi Chen,et al. Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells , 2005, Molecular and Cellular Biology.
[107] Frank R Burden,et al. Broad-based quantitative structure-activity relationship modeling of potency and selectivity of farnesyltransferase inhibitors using a Bayesian regularized neural network. , 2004, Journal of medicinal chemistry.
[108] Frank R. Burden,et al. Robust QSAR Models from Novel Descriptors and Bayesian Regularised Neural Networks , 2000 .
[109] Ireneusz Zbicinski,et al. Modelling of thermal degradation process dynamics of bioproducts using artificial neural networks , 1996 .
[110] P. Robson,et al. Oct4 and Sox2 Directly Regulate Expression of Another Pluripotency Transcription Factor, Zfp206, in Embryonic Stem Cells* , 2007, Journal of Biological Chemistry.
[111] J N Weinstein,et al. Neural network techniques for informatics of cancer drug discovery. , 2000, Methods in Enzymology.
[112] R. Callard,et al. From the top down: towards a predictive biology of signalling networks. , 2003, Trends in biotechnology.
[113] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[114] Carsten Peterson,et al. Random Boolean network models and the yeast transcriptional network , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[115] David A Winkler,et al. Predictive Bayesian neural network models of MHC class II peptide binding. , 2005, Journal of molecular graphics & modelling.
[116] A. Sharov,et al. Dynamics of global gene expression changes during mouse preimplantation development. , 2004, Developmental cell.
[117] J. Gasteiger,et al. The beauty of molecular surfaces as revealed by self-organizing neural networks. , 1994, Journal of molecular graphics.
[118] Frank R. Burden,et al. Bayesian neural nets for modeling in drug discovery , 2004 .
[119] Hsinchun Chen,et al. Large-scale regulatory network analysis from microarray data: modified Bayesian network learning and association rule mining , 2007, Decis. Support Syst..
[120] Julianne D. Halley,et al. Toward a Rosetta stone for the stem cell genome: stochastic gene expression, network architecture, and external influences. , 2008, Stem cell research.
[121] V. Plerou,et al. Scale invariance and universality: organizing principles in complex systems , 2000 .
[122] Gregory A Landrum,et al. Building predictive ADMET models for early decisions in drug discovery. , 2004, Current opinion in drug discovery & development.
[123] Paul Havlak,et al. Scale-invariant structure of strongly conserved sequence in genomic intersections and alignments , 2006, Proceedings of the National Academy of Sciences.